MARKET

BIAFW

BIAFW

bioAffinity Tech
NASDAQ
0.2201
0.00
0.00%
Opening 09:30 05/20 EDT
OPEN
--
PREV CLOSE
0.2201
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.8121
52 WEEK LOW
0.0525
MARKET CAP
--
P/E (TTM)
-0.0194
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIAF last week (0511-0515)?
Weekly Report · 2d ago
BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung
NASDAQ · 6d ago
bioAffinity CyPath Lung Test Sales Surge Sharply
TipRanks · 05/12 14:14
BioAffinity Technologies Reports April CyPath Lung Diagnostic Unit Sales Up 300% YoY
Benzinga · 05/12 13:24
BioAffinity says CyPath Lung test unit sales achieved monthly record in April
TipRanks · 05/12 13:24
bioAffinity Technologies Reports Record Monthly Unit Sales Of CyPath Lung Diagnostic Tests, 300% Increase In Sales YoY
Benzinga · 05/12 13:19
bioAffinity reports April CyPath Lung unit sales jump nearly 300% year over year
PUBT · 05/12 13:15
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026
Barchart · 05/12 08:15
More
About BIAFW
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatment. Its segments include Diagnostic Research and Development (R&D) and Laboratory Services. Its Diagnostic R&D segment includes research and development and clinical development on diagnostic tests. Its Laboratory services include all the operations of Village Oaks and PPLS, in addition to sales and marketing of CyPath Lung from bioAffinity. Its first product, CyPath Lung, addresses the need for noninvasive detection of early-stage lung cancer. The CyPath Lung test enables physicians to more confidently identify patients who will likely benefit from timely intervention and more invasive follow-up procedures and those who are likely without lung cancer and should continue routine screening.

Webull offers bioAffinity Technologies Inc stock information, including NASDAQ: BIAFW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIAFW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIAFW stock methods without spending real money on the virtual paper trading platform.